LONA

LeonaBio, Inc.

Regulated industry Physical products Sells to businesses Development stageTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $4.38
52-Week Range: $2.21 – $14.21
Market Cap: $45.41M
P/E (TTM): —
EPS (TTM): -23.01
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 1.35
PEG Ratio: —
Return on Equity: -431.39%
Return on Assets: -74.06%
Gross Margin: 0.00%
Operating Margin: 0.00%
Profit Margin: 0.00%
Current Ratio: 7.01
Debt/Equity: 0.02
Total Debt: $577.00K
Free Cash Flow: $-23.14M
Revenue Growth: —
Earnings Growth: —
Enterprise Value: $-5.08M

LONA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$0.00	$0.00	$0.00	$0.00
Research & Development	$61.46M	$93.79M	$70.68M	$17.50M
Selling, General & Admin	$32.55M	$33.30M	$26.09M	$16.68M
Operating Expenses	$88.86M	$126.94M	$96.78M	$34.18M
Operating Income	-$88.86M	-$126.94M	-$96.78M	-$34.18M
EBITDA	-$88.01M	-$125.97M	-$95.81M	-$33.21M
Pretax Income	-$95.64M	-$117.67M	-$96.94M	-$105.61M
Net Income	-$95.64M	-$117.67M	-$96.94M	-$105.61M
Diluted EPS	-25.30	-30.90	-25.20	-24.70
Diluted Shares	3.77M	3.80M	3.85M	4.28M

LONA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$95.97M	$90.58M	$48.44M	$69.28M
Receivables	$1.23M	$1.63M	$0.00	—
Current Assets	$207.53M	$154.73M	$54.84M	$89.46M
Total Assets	$258.15M	$160.25M	$58.78M	$92.15M
Current Liabilities	$21.43M	$28.84M	$13.13M	$47.50M
Total Debt	$1.91M	$1.58M	$1.22M	$803.00K
Total Liabilities	$23.02M	$30.06M	$13.94M	$64.36M
Retained Earnings	-$191.53M	-$309.21M	-$406.15M	-$511.75M
Shareholders' Equity	$235.14M	$130.19M	$44.84M	$27.79M
Working Capital	$186.10M	$125.89M	$41.71M	$41.95M

LONA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$72.47M	-$100.75M	-$97.17M	-$45.73M
Capital Expenditure	-$1.14M	-$304.00K	-$33.00K	—
Free Cash Flow	-$73.61M	-$101.06M	-$97.20M	-$45.73M
Depreciation & Amortisation	$845.00K	$969.00K	$970.00K	$972.00K
Stock-Based Compensation	$10.61M	$10.62M	$11.05M	$6.10M
Investing Cash Flow	$57.66M	$95.09M	$54.83M	-$15.89M
Financing Cash Flow	$654.00K	$493.00K	$194.00K	$82.46M
Net Change in Cash	-$14.15M	-$5.17M	-$42.15M	$20.84M

LONA Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Research & Development	$4.30M	$3.66M	$2.83M	$6.71M	$11.26M	$12.70M
Selling, General & Admin	$5.23M	$3.63M	$4.05M	$3.77M	$6.88M	$6.58M
Operating Expenses	$9.54M	$7.29M	$6.87M	$10.48M	$18.14M	$19.28M
Operating Income	-$9.54M	-$7.29M	-$6.87M	-$10.48M	-$18.14M	-$19.28M
EBITDA	-$9.29M	-$7.05M	-$6.63M	-$10.23M	-$17.91M	-$19.05M
Pretax Income	-$9.14M	-$6.97M	-$6.61M	-$82.89M	-$32.95M	-$19.01M
Net Income	-$9.14M	-$6.97M	-$6.61M	-$82.89M	-$32.95M	-$19.01M
Diluted EPS	-2.34	-1.78	-1.68	—	-1.73	-0.80
Diluted Shares	3.90M	3.91M	3.94M	—	19.03M	23.73M

LONA Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$26.42M	$19.89M	$20.87M	$69.28M	$32.83M	$32.32M
Current Assets	$39.85M	$32.22M	$27.02M	$89.46M	$69.20M	$54.81M
Total Assets	$43.51M	$35.55M	$30.03M	$92.15M	$71.59M	$56.89M
Current Liabilities	$5.49M	$2.98M	$2.79M	$47.50M	$6.67M	$7.82M
Total Debt	$1.12M	$1.02M	$912.00K	$803.00K	$691.00K	$577.00K
Total Liabilities	$6.18M	$3.56M	$3.25M	$64.36M	$22.29M	$23.30M
Retained Earnings	-$415.29M	-$422.25M	-$428.87M	-$511.75M	-$544.70M	-$563.71M
Shareholders' Equity	$37.33M	$31.99M	$26.79M	$27.79M	$49.30M	$33.59M
Working Capital	$34.36M	$29.24M	$24.24M	$41.95M	$62.54M	$46.99M

LONA Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	-$14.66M	-$7.00M	-$4.67M	-$19.40M	-$20.90M	-$16.96M
Free Cash Flow	-$14.66M	-$7.00M	-$4.67M	-$19.40M	-$20.90M	-$16.96M
Depreciation & Amortisation	$243.00K	$243.00K	$243.00K	$243.00K	$231.00K	$227.00K
Stock-Based Compensation	$1.64M	$1.60M	$1.41M	$1.46M	$662.00K	$3.18M
Investing Cash Flow	-$7.35M	$441.00K	$5.65M	-$14.64M	-$15.54M	$16.33M
Financing Cash Flow	$0.00	$24.00K	$0.00	$82.44M	$0.00	$114.00K
Net Change in Cash	-$22.02M	-$6.53M	$986.00K	$48.40M	-$36.44M	-$510.00K

Market Snapshot

About

LeonaBio, Inc. is a biotechnology company focused on developing novel therapeutics for serious medical conditions. The company leverages advanced research platforms to discover and develop drug candidates. LeonaBio aims to address unmet medical needs through innovative biopharmaceutical solutions.